Vildagliptin CAS 274901-16-5

Product Description:

Product Name: Vildagliptin CAS NO:274901-16-5

Synonyms:

Laf 237; NVP-LAF 237;

(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile;

1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine;

Chemical & Physical Properties:

Appearance : White crystalline powder

Assay : ≥99.0%

Density: 1.27g/cm³

Melting Point: 148.0℃～152℃

Boiling Point: 531.3℃ at 760 mmHg

Flash Point: 275.1℃

Refractive Index: 1.564

Vapor Pressure: 0mmHg at 25°C

PSA: 76.36000

LogP: 1.50308

Solubility: DMSO (Slightly), Methanol (Slightly).

Category: Standards; Pharmaceutical/API Drug Impurities/Metabolites;

Safety Information:

HS Code: 2933990090

Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.

Application: 

Vildagliptin is a dipeptidyl peptidase-4 inhibitor class of oral antidiabetic drugs used to treat type 2 diabetes mellitus. Vildagliptin is the only substance that can inhibit glucagon in both hyperglycemia and hypoglycemia. Aside from their use in type 2 diabetes, Vildagliptin have positive cardiovascular and anti-inflammtatory effects and Antidiabetic.

Glyptins are class of oral anti-hyperglycemic agents that inhibit dipeptidyl peptidase 4 (DPP-4), which can act as a serine exopeptidase.

Our factory manufacture’s Vildagliptin CAS 274901-16-5, mature technology, stable output, quality assurance.

Delivery deadline: from stock

We can provide (2S)-1-((3-hydroxyadamantan-1-yl)glycyl)pyrrolidine-2-carbonitrile COA, (S)-1-(2-(((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile MOA, (S)-1-[2-[(3-Hydroxyadamant-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile ROS, (-)-(2S)-1-[[(3-Hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile MSDS and other support for you !

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.

http://www.hsppharma.com/